Abstract | UNLABELLED:
Angiotensin II (Ang II) is implicated in atherogenesis by activating inflammatory responses in arterial wall cells. Ang II accelerates the atherosclerotic process in hyperlipidemic apoE-/- mice by recruiting and activating monocytes. Monocyte chemoattractant protein-1 (MCP-1) controls monocyte-mediated inflammation through its receptor, CCR2. The roles of leukocyte-derived CCR2 in the Ang II-induced acceleration of the atherosclerotic process, however, are not known. We hypothesized that deficiency of leukocyte-derived CCR2 suppresses Ang II-induced atherosclerosis. METHODS AND RESULTS: CONCLUSIONS:
|
Authors | Minako Ishibashi, Kensuke Egashira, Qingwei Zhao, Ken-ichi Hiasa, Kisho Ohtani, Yoshiko Ihara, Israel F Charo, Shinobu Kura, Teruhisa Tsuzuki, Akira Takeshita, Kenji Sunagawa |
Journal | Arteriosclerosis, thrombosis, and vascular biology
(Arterioscler Thromb Vasc Biol)
Vol. 24
Issue 11
Pg. e174-8
(Nov 2004)
ISSN: 1524-4636 [Electronic] United States |
PMID | 15331433
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Apolipoproteins E
- Ccr2 protein, mouse
- Receptors, CCR2
- Receptors, Chemokine
- Angiotensin II
|
Topics |
- Angiotensin II
(metabolism)
- Animals
- Aortic Aneurysm, Abdominal
(etiology)
- Apolipoproteins E
(deficiency)
- Arteriosclerosis
(pathology)
- Bone Marrow
(chemistry)
- Bone Marrow Transplantation
(methods)
- Leukocytes
(chemistry, metabolism)
- Male
- Mice
- Mice, Inbred C57BL
- Mice, Inbred Strains
- Monocytes
(chemistry, metabolism)
- Receptors, CCR2
- Receptors, Chemokine
(deficiency, physiology)
|